Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress

被引:43
|
作者
Cookson, MR
Menzies, FM
Manning, P
Eggett, CJ
Figlewicz, DA
McNeil, CJ
Shaw, PJ
机构
[1] Univ Sheffield, Sch Med, Dept Neurol, Acad Neurol Unit, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Newcastle Upon Tyne, Dept Clin Biochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Univ Rochester, Dept Neurol & Neurobiol & Anat, Rochester, NY 14627 USA
关键词
amyotrophic lateral sclerosis; SOD1; mutations; nitric oxide; superoxide; neuroprotection;
D O I
10.1080/146608202760196048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: The exact molecular mechanisms by which mutations in Cu/Zn superoxide dismutase (SOD1) cause motor neuron injury remain incompletely understood, though a body of evidence suggests that the mutant protein exerts a cell-specific toxic gain of function. The role of nitric oxide (NO) in SOD1-related motor neuron injury has been particularly controversial. Theoretically, there are arguments to suggest that NO may exert an important role in motor neuron injury, but there is relatively little direct experimental support for this hypothesis. Objectives: The present study aimed to examine further the potential role for NO in motor neuron injury caused by mutant SOD1. Method: We have generated a cellular model of familial amyotrophic lateral sclerosis (ALS) by stably transfecting NSC34 cells with one of three mutant forms of SOD1 (G93A, G37R, I113T). In the presence of mutant SOD1, NSC34 cells show increased cell death following oxidative stress induced by serum withdrawal. This model of motor neuron death involves cellular release of superoxide and NO radicals, which were directly measured in real time using microelectrode biosensors. Results: The expression of both normal and mutant SOD1 decreased the measured extracellular superoxide release, but had divergent effects on the measured release of NO. Normal SOD1 increased the measured NO release, whereas cells expressing mutant SOD1 released less NO. Co-administration of two different nitric oxide synthase inhibitors (L-NAME and L-N-methyl arginine) did show some neuroprotective effect, but this was only partial, and the effect was more marked using nuclear integrity as a measure of cell viability, rather than MTT conversion. Cells expressing mutant SOD1 were, however, more sensitive to toxicity induced by extrinsic exposure to NO, using a slow-release NO donor. Conclusion: NO is likely to contribute to motor neuron injury, but this does not fully account for all the cellular toxic effects of mutant SOD1.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
  • [1] MUTATIONS IN CU/ZN SUPEROXIDE-DISMUTASE (SOD1) ARE ASSOCIATED WITH FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS (ALS)
    BROWN, RH
    FREE RADICAL BIOLOGY AND MEDICINE, 1993, 15 (05) : 471 - 471
  • [2] CU/ZN SUPEROXIDE-DISMUTASE (SOD1) MUTATIONS AND SPORADIC AMYOTROPHIC-LATERAL-SCLEROSIS
    JONES, CT
    BROCK, DJH
    CHANCELLOR, AM
    WARLOW, CP
    SWINGLER, RJ
    LANCET, 1993, 342 (8878): : 1050 - 1051
  • [4] Cu/Zn superoxide dismutase (SOD1) mutations in amyotrophic lateral sclerosis (ALS) CNS tissue: Exclusion of somatic mutations and correlations with molecular pathology
    Shaw, PJ
    Tomkins, J
    Ince, PG
    Slade, JY
    Usher, P
    Curtis, A
    Bushby, K
    NEUROLOGY, 1997, 48 (03) : 49005 - 49005
  • [5] A yeast model for superoxide dismutase (SOD1) triggered amyotrophic lateral sclerosis (ALS)
    Bastow, Emma L.
    Rowe, Michelle
    Howard, Mark
    Tarrant, Daniel S. J.
    Gourlay, Campbell W.
    Tuite, Mick F.
    YEAST, 2013, 30 : 79 - 79
  • [6] Increased immunoreactivity of Cu/Zn superoxide dismutase (SOD1) in the skin of sporadic amyotrophic lateral sclerosis
    Ono, S.
    Yasui, K.
    Ishikawa, H.
    Nomura, M.
    Watanabe, T.
    Mikami, H.
    Suzuki, M.
    JOURNAL OF NEUROLOGY, 2010, 257 : S112 - S113
  • [7] Pyrimethamine Significantly Lowers Cerebrospinal Fluid Cu/Zn Superoxide Dismutase in Amyotrophic Lateral Sclerosis Patients with SOD1 Mutations
    Lange, Dale J.
    Shahbazi, Mona
    Silani, Vincenzo
    Ludolph, Albert C.
    Weishaupt, Jochen H.
    Ajroud-Driss, Senda
    Fields, Kara G.
    Remanan, Rahul
    Appel, Stanley H.
    Morelli, Claudia
    Doretti, Alberto
    Maderna, Luca
    Messina, Stefano
    Weiland, Ulrike
    Marklund, Stefan L.
    Andersen, Peter M.
    ANNALS OF NEUROLOGY, 2017, 81 (06) : 837 - 848
  • [8] Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations
    Orrell, RW
    NEUROMUSCULAR DISORDERS, 2000, 10 (01) : 63 - 68
  • [9] MUTATIONS IN CU/ZN SUPEROXIDE-DISMUTASE GENE ARE ASSOCIATED WITH FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS
    ROSEN, DR
    SIDDIQUE, T
    PATTERSON, D
    FIGLEWICZ, DA
    SAPP, P
    HENTATI, A
    DONALDSON, D
    GOTO, J
    OREGAN, JP
    DENG, HX
    RAHMANI, Z
    KRIZUS, A
    MCKENNAYASEK, D
    CAYABYAB, A
    GASTON, SM
    BERGER, R
    TANZI, RE
    HALPERIN, JJ
    HERZFELDT, B
    VANDENBERGH, R
    HUNG, WY
    BIRD, T
    DENG, G
    MULDER, DW
    SMYTH, C
    LAING, NG
    SORIANO, E
    PERICAKVANCE, MA
    HAINES, J
    ROULEAU, GA
    GUSELLA, JS
    HORVITZ, HR
    BROWN, RH
    NATURE, 1993, 362 (6415) : 59 - 62
  • [10] The absence of abnormal Cn/Zn superoxide dismutase (SOD1) in familial amyotrophic lateral sclerosis with two basepair deletion in the SOD1 Gene
    Watanabe, Y
    Kono, Y
    Nanba, E
    Nakashima, K
    Kato, S
    Ohama, E
    Takahashi, K
    AMYOTROPHIC LATERAL SCLEROSIS: PROGRESS AND PERSPECTIVES IN BASIC RESEARCH AND CLINICAL APPLICATION, 1996, 1104 : 281 - 284